Skip to main content
. Author manuscript; available in PMC: 2012 Aug 27.
Published in final edited form as: Mol Immunol. 2008 Nov 28;46(5):893–901. doi: 10.1016/j.molimm.2008.09.015

Figure 1. Circulating mDC and pDC in RCC patients.

Figure 1

(A). Blood samples were obtained from 30 RCC patients and 40 healthy volunteers. Four-color flow cytometry was used to distinguish mDC and pDC subsets within freshly-isolated peripheral blood mononuclear cells using specific antibodies directed against mDC1 (anti-BDCA1), mDC2 (anti-BDCA3), and pDC (anti-BDCA2). * P< 0.01 for all tested subpopulations. (B). The frequency of DC subsets in metastatic RCC patients (METS) vs. patients with no evidence of disease (NED) at last clinic evaluation of disease. * P<0.05; ** P<0.01.